nejm semaglutide ckd Semaglutide, Chronic Kidney Disease, and Diabetes Presented at the 61st ERA

Kotas ME, Medzhitov R

Semaglutide may also be considered for patients with type 2 diabetes who have not achieved their desired blood sugar control with lifestyle changes and other medications

2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans

In the current environment, that data has taken on a new dimension: it maps not just when exclusivity expires, but which drugs are most exposed to cost-plus disruption once exclusivity does expire or even before it does, in cases where cost-plus channels access comparable molecules legally through existing generic or biosimilar markets

W., Ryan, D

The appeal here is, frankly, undeniable